Scientists at Scripps Research have developed a new blood test that can predict type 1 diabetes with 100% accuracy in a small sample. The test analyzes a certain type of immune cell called a T cell to identify people who have active autoimmunity, the process that underlies type 1 diabetes.
The test is still in the early stages of development, but it has the potential to revolutionize the way type 1 diabetes is diagnosed and treated. By identifying people who are at risk of developing the disease early on, doctors can intervene with treatment to delay or even prevent its onset.
This is a major breakthrough in the field of type 1 diabetes research, and it offers hope to millions of people who are at risk of developing the disease.